Journal
NATURE IMMUNOLOGY
Volume 21, Issue 11, Pages 1397-+Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41590-020-0786-2
Keywords
-
Categories
Funding
- Core Unit SysMed of the IZKF Wurzburg
- German Research Foundation [SFB TR 221]
- German Research Foundation Emmy Noether programme [GA2129/2-1]
- European Research Council [819329, 759176]
- Max Planck Society (Max Planck Research Groups)
- Germany's Excellence Strategy [EXC2151, 390873048]
- European Research Council (ERC) [819329, 759176] Funding Source: European Research Council (ERC)
Ask authors/readers for more resources
BATF3 is a member of the AP-1 transcription factor family. Kastenmuller and colleagues show that BATF3 is needed to promote memory CD8(+)T cell responses. Activated CD8(+)T cells transiently upregulate BATF3, which in turn suppresses expression of proapoptotic BIM to promote cell survival. Antiviral CD8(+)T cell responses are characterized by an initial activation/priming of T lymphocytes followed by a massive proliferation, subset differentiation, population contraction and the development of a stable memory pool. The transcription factor BATF3 has been shown to play a central role in the development of conventional dendritic cells, which in turn are critical for optimal priming of CD8(+)T cells. Here we show that BATF3 was expressed transiently within the first days after T cell priming and had long-lasting T cell-intrinsic effects. T cells that lackedBatf3showed normal expansion and differentiation, yet succumbed to an aggravated contraction and had a diminished memory response. Vice versa, BATF3 overexpression in CD8(+)T cells promoted their survival and transition to memory. Mechanistically, BATF3 regulated T cell apoptosis and longevity via the proapoptotic factor BIM. By programing CD8(+)T cell survival and memory, BATF3 is a promising molecule to optimize adoptive T cell therapy in patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available